HB 1355 – Maryland

Status: Inactive / Dead
Year Introduced: 2022
Link: https://mgaleg.maryland.gov/mgawebsite/Legislation/Details/hb1355/?ys=2022rs

Health Insurance – Prescription Insulin Drugs – Limits on Copayment and Coinsurance. Requiring health insurance carriers to limit the amount a covered individual is required to pay in copayments or coinsurance for a covered prescription insulin drug to $30 for a 30-day supply; and requiring the Prescription Drug Affordability Board to conduct a certain cost review of prescription insulin drug products.

Return to Database Search

© 2018- The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Associated Litigation:

No items found